Form 4 for ARQT Arcutis Biotherapeutics, Inc.
Accepted 2023-12-22 00:00:00 ET · period of report 2023-12-20 · accession 0001787306-23-000134 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-12-22 | 2023-12-20 | ARQT | Watanabe Todd Franklin | See Remarks, Dir | G - Gift | $0.00 | -13.1K | 502.0K | -3% | $0 |
| MI | 2023-12-22 | 2023-12-20 | ARQT | Watanabe Todd Franklin | See Remarks, Dir | G - Gift | $0.00 | +13.1K | 24.4K | +116% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-20 | G | D | 6,563 | $0.00 | 508,582 | D By Trust | — | — | (F1) The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust. |
| 2 | Common | Common Stock | 2023-12-20 | G | D | 6,563 | $0.00 | 502,019 | D By Trust | — | — | (F2) The securities are held of record by The John Franklin Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust. |
| 3 | Common | Common Stock | 2023-12-20 | G | A | 6,563 | $0.00 | 24,413 | I | — | — | |
| 4 | Common | Common Stock | 2023-12-20 | G | A | 6,563 | $0.00 | 24,413 | I | — | — |